Reducing Avoidable Transfer Delays in the Pediatric Intensive Care Unit for Status Asthmaticus Patients

Takaharu Karube1, Theresa Goins2, Todd J Karsies1

  • 1Department of Pediatrics, Division of Pediatric Critical Care Medicine, Nationwide Children's Hospital, Columbus, Ohio.

Insights

Implementing standardized transfer criteria and multidisciplinary interventions significantly reduced Pediatric Intensive Care Unit (PICU) discharge delays for patients with status asthmaticus (acute severe asthma). This improved PICU capacity and patient flow without increasing readmissions.

Area of Science:

  • Pediatric Critical Care Medicine
  • Quality Improvement Science
  • Health Systems Management

Background:

  • Status asthmaticus is a leading cause of Pediatric Intensive Care Unit (PICU) admission, necessitating efficient patient throughput.
  • Optimizing PICU capacity requires minimizing delays in patient discharge.
  • Limited research exists on effective strategies to expedite PICU discharge for status asthmaticus patients.

Purpose of the Study:

  • To identify and reduce avoidable delays in PICU discharge for patients with status asthmaticus.
  • To decrease the average time from meeting transfer criteria to PICU discharge by 15%.

Main Methods:

  • A quality improvement project was conducted at a children's hospital.
  • Standardized transfer criteria and implemented multidisciplinary interventions.
  • Monitored the duration from transfer criteria fulfillment to discharge and PICU readmission rates.

Main Results:

  • Reduced the average time from transfer criteria fulfillment to PICU discharge by 30.6% (from 9.8 to 6.8 hours).
  • Sustained improvements for at least 6 months post-intervention.
  • Eliminated PICU readmissions within 24 hours for asthma exacerbations.

Conclusions:

  • Standardizing transfer criteria and employing multidisciplinary strategies effectively reduce PICU discharge delays for status asthmaticus.
  • This approach can be applied to other conditions to minimize avoidable delays in the PICU.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
227
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
456
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
373
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
695